-
Rocilinostat (ACY-1215) Research Workflows
2026-08-11
Rocilinostat (ACY-1215) provides a selective HDAC6 perturbation strategy for multiple myeloma assays, combination studies, and mechanistic work on α-tubulin acetylation. This guide also explains how to cautiously extend HDAC6-focused workflows into primary-cilia and neurodevelopment research without confusing exploratory hypotheses with findings established by the SMPD4 reference study.
-
JSH-23: A Precision NF-κB Inhibitor
2026-08-11
JSH-23 is a small-molecule NF-κB inhibitor that suppresses p65 nuclear localization and DNA-binding activity without blocking IκB degradation. Product information supports its use in inflammation research, including LPS-stimulated macrophage studies and a cisplatin-induced acute kidney injury model.
-
T-5224: From Arthritis to Neuroinflammation
2026-08-10
T-5224 is a selective C-Fos/AP-1 inhibitor that gives translational researchers a way to test whether AP-1-dependent transcription connects inflammatory signaling with tissue remodeling and sensory sensitization. This article links validated arthritis models with emerging Ca2+-dependent neuroinflammatory biology while clearly separating established evidence from forward-looking experimental hypotheses.
-
DiI (DiIC18(3)) Membrane Probe Guide
2026-08-09
DiI (DiIC18(3)) provides orange-red fluorescence for labeling lipid-rich plasma membranes in live or fixed biological samples. It is suited to membrane-focused imaging, neuronal tracing, migration, fusion, adhesion, and lipoprotein workflows, but not to water-only protocols or organelle-specific staining.
-
PINK1 Deficiency in Bleomycin-Induced Fibrosis
2026-08-08
A 2025 study identifies a noncanonical role for PINK1 in bleomycin-induced pulmonary fibrosis: PINK1 deficiency enhances BNIP3- and FUNDC1-mediated mitophagy, limits epithelial apoptosis, and reduces fibrotic injury in mice. The findings refine interpretation of mitochondrial quality control in pulmonary fibrosis research and suggest that mitophagy pathways should be evaluated as a network rather than as a single linear cascade.
-
Auranofin Workflows for Redox Cancer Research
2026-08-07
A practical guide to using Auranofin as a thioredoxin reductase inhibitor in redox, apoptosis, radiosensitization, antimicrobial, and exploratory HCC metabolism studies. It combines product-backed concentration ranges with assay controls, workflow enhancements, and troubleshooting strategies that separate established evidence from testable hypotheses.
-
Integrated Protocols for mRNA LNP Formulation and Evaluation
2026-08-07
Ma et al. present a unified, stepwise protocol for formulating, characterizing, and evaluating mRNA lipid nanoparticles (LNPs), aiming to lower technical barriers in the field. This workflow standardizes key parameters and in vitro/in vivo assessments, advancing reproducibility and accessibility for mRNA delivery research.
-
Puromycin Dihydrochloride: Precision Selection for Translati
2026-08-06
Puromycin dihydrochloride, a cornerstone aminonucleoside antibiotic, is redefining translational research by enabling precise cell selection and high-fidelity studies of protein synthesis and ribosome function. This thought-leadership article integrates mechanistic insights, recent innovations in gene therapy vector targeting, and actionable protocol guidance to empower researchers navigating a competitive landscape. Moving beyond standard protocols, we examine how this molecule supports the next generation of cell and gene engineering, linking robust selection strategies with visionary advances in translational medicine.
-
Doxycycline as a Tetracycline Antibiotic in Cancer Research
2026-08-06
Doxycycline’s dual role as a tetracycline antibiotic and metalloproteinase inhibitor sets it apart for advanced cancer research and antimicrobial studies. This article delivers actionable workflows, protocol optimizations, and troubleshooting strategies that empower researchers to maximize the impact of APExBIO’s high-purity Doxycycline (BA1003) across experimental models.
-
Canagliflozin Hemihydrate: Precision SGLT2 Inhibition in Res
2026-08-05
Canagliflozin hemihydrate enables highly selective inhibition of renal glucose reabsorption, making it a gold-standard tool for dissecting glucose homeostasis pathways in metabolic disorder research. This article translates recent experimental advances into actionable protocols and troubleshooting strategies for maximizing the value of this compound in glucose metabolism and diabetes studies.
-
Temozolomide in ATRX-Deficient Glioma: Precision Chemistry f
2026-08-05
Explore how Temozolomide, a leading small-molecule alkylating agent, enables advanced, mutation-stratified DNA repair mechanism research in ATRX-deficient glioma. This article delivers new assay insights beyond standard protocols, uniquely integrating recent scientific breakthroughs with practical guidance.
-
Crossbreeding Impacts on Goose Meat: Multiomics Insights
2026-08-04
This study integrates transcriptomic and metabolomic analyses to assess how crossbreeding and sex affect slaughter performance and meat quality traits in Xingguo gray geese. The findings highlight molecular pathways underlying improved production metrics in hybrids, offering a foundation for precision breeding strategies in poultry.
-
DeferoxamineB in Advanced Cancer Models: Protocols & Innovat
2026-08-04
Deferoxamine (DeferoxamineB) is redefining cancer research by enabling precise control of iron-dependent cell death pathways. This article unpacks actionable workflows, protocol optimizations, and troubleshooting strategies—bridging cutting-edge metabolic interventions to robust, reproducible results.
-
SB525334: TGF-beta1 Receptor Inhibitor in Fibrosis Research
2026-08-03
SB525334 (TGF-beta1 receptor inhibitor) empowers precision modulation of TGF-beta signaling, enabling advanced fibrosis, wound healing, and osteo-immune research. This guide translates high-impact findings and hands-on troubleshooting into actionable protocols for both in vitro and in vivo applications.
-
UBE2F-SAG–Mediated RHEB Neddylation Drives mTORC1 in Liver C
2026-08-03
This study uncovers RHEB as a neddylation substrate of the UBE2F-SAG axis, revealing how this modification amplifies mTORC1 signaling and promotes liver tumorigenesis. The findings establish a novel regulatory mechanism with translational potential for hepatocellular carcinoma and related metabolic diseases.